-
1
-
-
33846457870
-
Cancer statistics, 2007
-
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57(1): 43-66.
-
(2007)
CA Cancer J Clin
, vol.57
, Issue.1
, pp. 43-66
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Murray, T.4
Xu, J.5
Thun, M.J.6
-
2
-
-
28244457959
-
-
Available from
-
International Agency for Research on Cancer. Globocan 2002. Available from: www-dep.iarc.fr/
-
Globocan 2002
-
-
-
4
-
-
0242624568
-
Uterine Cervical Carcinoma after Therapy: CT and MR Imaging Findings
-
Jeong YY, Kang HK, Chung TW, Seo JJ, Park JG. Uterine cervical carcinoma after therapy: CT and MR imaging findings. Radiographics 2003; 23: 969-80. (Pubitemid 37414772)
-
(2003)
Radiographics
, vol.23
, Issue.4
, pp. 969-980
-
-
Jeong, Y.Y.1
Kang, H.K.2
Chung, T.W.3
Seo, J.J.4
Park, J.G.5
-
5
-
-
33749127881
-
Management of cervical cancer
-
DOI 10.1016/j.ejso.2006.03.037, PII S074879830600151X, Gynaecological Cancers
-
Kesic V. Management of cervical cancer. Eur J Surg Oncol 2006; 32: 832-7. (Pubitemid 44469296)
-
(2006)
European Journal of Surgical Oncology
, vol.32
, Issue.8
, pp. 832-837
-
-
Kesic, V.1
-
6
-
-
33845190140
-
Carcinoma of the cervix uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer
-
Quinn MA, Benedet JL, Odicino F, Maisonneuve P, Beller U, Creasman WT, et al. Carcinoma of the cervix uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006; 95 (Suppl. 1): S43-S103.
-
(2006)
Int J Gynaecol Obstet
, vol.95
, Issue.SUPPL. 1
-
-
Quinn, M.A.1
Benedet, J.L.2
Odicino, F.3
Maisonneuve, P.4
Beller, U.5
Creasman, W.T.6
-
7
-
-
80052127750
-
-
v. 1 Available from
-
National Comprehensive Cancer Network. Cervical Cancer. Practice Guidelines in Oncology v. 1.2009. Available from: www.nccn.org/professionals/ physician-gls/PDF/cervical/pdf
-
(2009)
Cervical Cancer. Practice Guidelines in Oncology
-
-
-
8
-
-
0033766815
-
Diagnosis of recurrent uterine cervical cancer: Computed tomography versus positron emission tomography
-
Park DH, Kim KH, Park SY, Lee BH, Choi CW, Chin SY. Diagnosis of recurrent uterine cervical cancer: computed tomography versus positron emission tomography. Korean J Radiol 2000; 1: 51-5.
-
(2000)
Korean J Radiol
, vol.1
, pp. 51-55
-
-
Park, D.H.1
Kim, K.H.2
Park, S.Y.3
Lee, B.H.4
Choi, C.W.5
Chin, S.Y.6
-
9
-
-
56349109845
-
New trends in the evaluation and treatment of cervical cancer: The role of FDG-PET
-
Magné N, Chargari C, Vicenzi L, Gillon N, Messai T, Magné J, et al. New trends in the evaluation and treatment of cervical cancer: the role of FDG-PET. Cancer Treat Rev 2008; 34: 671-81.
-
(2008)
Cancer Treat Rev
, vol.34
, pp. 671-681
-
-
Magné, N.1
Chargari, C.2
Vicenzi, L.3
Gillon, N.4
Messai, T.5
Magné, J.6
-
10
-
-
33846207786
-
Positron emission tomography imaging for gynecologic malignancy
-
Lai CH, Yen TC, Chang TC. Positron emission tomography imaging for gynecologic malignancy. Curr Opin Obstet Gynecol 2007; 19: 37-41.
-
(2007)
Curr Opin Obstet Gynecol
, vol.19
, pp. 37-41
-
-
Lai, C.H.1
Yen, T.C.2
Chang, T.C.3
-
11
-
-
0035296491
-
Clinical role of positron emission tomography in oncology
-
DOI 10.1016/S1470-2045(00)00257-6, PII S1470204500002576
-
Bomanji JB, Costa DC, Eli PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol 2001; 3: 157-64. (Pubitemid 33585927)
-
(2001)
Lancet Oncology
, vol.2
, Issue.3
, pp. 157-164
-
-
Bomanji, J.B.1
Costa, D.C.2
Ell, P.J.3
-
13
-
-
1842503945
-
18F-FDG uptake in the squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression
-
18F-FDG uptake in the squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. J Nucl Med 2004; 45: 22-9.
-
(2004)
J Nucl Med
, vol.45
, pp. 22-29
-
-
Yen, T.C.1
See, L.C.2
Lai, C.H.3
Yah-Huei, C.W.4
Ng, K.K.5
Ma, S.Y.6
-
14
-
-
33748545361
-
Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: From diagnosis to prognosis
-
DOI 10.1016/j.ygyno.2006.02.016, PII S0090825806001788
-
Chung HH, Kim SK, Kim TH, Lee S, Kang KW, Kim JY, Park SY. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine-cervical cancer: from diagnosis to prognosis. Gynecol Oncol 2006; 103: 165-70. (Pubitemid 44374686)
-
(2006)
Gynecologic Oncology
, vol.103
, Issue.1
, pp. 165-170
-
-
Chung, H.H.1
Kim, S.-K.2
Kim, T.H.3
Lee, S.4
Kang, K.W.5
Kim, J.-Y.6
Park, S.-Y.7
-
15
-
-
32644488140
-
FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy-tumor volume and FDG uptake value
-
DOI 10.1016/j.ygyno.2005.09.030, PII S0090825805008243
-
Sakurai H, Suzuki Y, Nonaka T, Ishikawa H, Shioya M, Kiyohara H, et al. FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapy-tumor volume and FDG uptake value. Gynecol Oncol 2006; 100: 601-7. (Pubitemid 43246878)
-
(2006)
Gynecologic Oncology
, vol.100
, Issue.3
, pp. 601-607
-
-
Sakurai, H.1
Suzuki, Y.2
Nonaka, T.3
Ishikawa, H.4
Shioya, M.5
Kiyohara, H.6
Katoh, H.7
Nakayama, Y.8
Hasegawa, M.9
Nakano, T.10
-
16
-
-
3242665435
-
Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women
-
DOI 10.1016/j.ygyno.2004.04.021, PII S0090825804003051
-
Unger JB, Ivy JJ, Connor P, Charrier A, Ramaswamy RR, Ampil FL, Monsour RP. Detection of recurrent cervical cancer by whole-body FDG-PET scan in asymptomatic and symptomatic women. Gynecol Oncol 2004; 94: 212-6. (Pubitemid 38950523)
-
(2004)
Gynecologic Oncology
, vol.94
, Issue.1
, pp. 212-216
-
-
Unger, J.B.1
Ivy, J.J.2
Connor, P.3
Charrier, A.4
Ramaswamy, M.R.5
Ampil, F.L.6
Monsour, R.P.7
-
17
-
-
0038500701
-
The role of PET scanning in the detection of recurrent cervical cancer
-
Havrilesky LJ, Wong TZ, Álvarez-Secord A, Berchuk A, Clarke-Pearson DL, Jones EL. The role of PET scanning in the detection of recurrent cervical cancer. Gynecol Oncol 2003; 90: 186-90.
-
(2003)
Gynecol Oncol
, vol.90
, pp. 186-190
-
-
Havrilesky, L.J.1
Wong, T.Z.2
Álvarez-Secord, A.3
Berchuk, A.4
Clarke-Pearson, D.L.5
Jones, E.L.6
-
18
-
-
0037363332
-
Detection of early recurrence with 18F-FDG PET in patients with cervical cancer
-
Ryu SY, Kim MH, Choi SC, Choi CW, Lee KH. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J Nucl Med 2003; 44: 347-52.
-
(2003)
J Nucl Med
, vol.44
, pp. 347-352
-
-
Ryu, S.Y.1
Kim, M.H.2
Choi, S.C.3
Choi, C.W.4
Lee, K.H.5
-
19
-
-
37349018274
-
Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings
-
DOI 10.1016/j.ygyno.2007.09.011, PII S0090825807007536
-
Yildirim Y, Sehirali S, Avci ME, Yilmaz C, Ertopcu K, Tinar S, et al. Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings. Gynecol Oncol 2008; 108: 154-9. (Pubitemid 350299438)
-
(2008)
Gynecologic Oncology
, vol.108
, Issue.1
, pp. 154-159
-
-
Yildirim, Y.1
Sehirali, S.2
Avci, M.E.3
Yilmaz, C.4
Ertopcu, K.5
Tinar, S.6
Duman, Y.7
Sayhan, S.8
-
20
-
-
29444450845
-
Lymph node metastasis in patients with clinical early-stage cervical cancer: Detection with integrated FDG PET/CT
-
DOI 10.1148/radiol.2381041799
-
Sironi S, Buda A, Picchio M, Perego P, Moreni R, Pellegrino A, et al. Lymph-node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG-PET/CT. Radiology 2006; 238: 272-9. (Pubitemid 43010605)
-
(2006)
Radiology
, vol.238
, Issue.1
, pp. 272-279
-
-
Sironi, S.1
Buda, A.2
Picchio, M.3
Perego, P.4
Moreni, R.5
Pellegrino, A.6
Colombo, M.7
Mangioni, C.8
Messa, C.9
Fazio, F.10
-
21
-
-
33846934486
-
Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence
-
DOI 10.1016/j.ygyno.2006.09.009, PII S0090825806007165
-
Chung HH, Jo H, Kang WJ, Kim JW, Park NH, Song YS, et al. Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence. Gynecol Oncol 2007; 104: 529-34. (Pubitemid 46240239)
-
(2007)
Gynecologic Oncology
, vol.104
, Issue.3
, pp. 529-534
-
-
Chung, H.H.1
Jo, H.2
Kang, W.J.3
Kim, J.W.4
Park, N.-H.5
Song, Y.-S.6
Chung, J.-K.7
Kang, S.-B.8
Lee, H.-P.9
-
23
-
-
29144506286
-
The role of hybrid PET/CT in the evaluation of patients with cervical cancer
-
DOI 10.1016/j.ygyno.2005.07.013, PII S0090825805006050
-
Amit A, Beck D, Lowenstein L, Lavie O, Bar Shalom R, Kedar Z, Israel O. The role of hybrid PET/CT in the evaluation of patients with cervical cancer. Gynecol Oncol 2006; 100: 65-9. (Pubitemid 41815051)
-
(2006)
Gynecologic Oncology
, vol.100
, Issue.1
, pp. 65-69
-
-
Amit, A.1
Beck, D.2
Lowenstein, L.3
Lavie, O.4
Bar, S.R.5
Kedar, Z.6
Israel, O.7
-
24
-
-
0033019972
-
Evaluation of FDG PET in patients with cervical cancer
-
Sugawara Y, Eisbruch A, Kosuda S, Recker BE, Kison PV, Wahl RL. Evaluation of FDG PET in patients with cervical cancer. J Nucl Med 1999; 40: 1125-31. (Pubitemid 29315502)
-
(1999)
Journal of Nuclear Medicine
, vol.40
, Issue.7
, pp. 1125-1131
-
-
Sugawara, Y.1
Eisbruch, A.2
Kosuda, S.3
Recker, B.E.4
Kison, P.V.5
Wahl, R.L.6
-
25
-
-
52049116307
-
Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer
-
Kitajima K, Murakami K, Yamasaki E, Domeki Y, Kaji Y, Sugimura K. Performance of FDG-PET/CT for diagnosis of recurrent uterine cervical cancer. Eur Radiol 2008; 18: 2040-7.
-
(2008)
Eur Radiol
, vol.18
, pp. 2040-2047
-
-
Kitajima, K.1
Murakami, K.2
Yamasaki, E.3
Domeki, Y.4
Kaji, Y.5
Sugimura, K.6
-
26
-
-
60549110475
-
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis in recurrent uterine cancer: Comparison with PET and enhanced CT
-
Kitajima K, Murakami K, Yamasaki E, Domeki Y, Kaji Y, Monta S, et al. Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis in recurrent uterine cancer: comparison with PET and enhanced CT. Eur J Nucl Med Mol Imag 2009; 36: 362-72.
-
(2009)
Eur J Nucl Med Mol Imag
, vol.36
, pp. 362-372
-
-
Kitajima, K.1
Murakami, K.2
Yamasaki, E.3
Domeki, Y.4
Kaji, Y.5
Monta, S.6
-
27
-
-
1242298715
-
18F] fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer
-
DOI 10.1016/j.mibio.2003.12.004, PII S1536163203002415
-
Wong TZ, Jones EL, Coleman RE. Positron emission tomography with 2-deoxy-2[(18)F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer. Mol Imag Biol 2004; 6: 55-62. (Pubitemid 38240359)
-
(2004)
Molecular Imaging and Biology
, vol.6
, Issue.1
, pp. 55-62
-
-
Wong, T.Z.1
Jones, E.L.2
Coleman, R.E.3
-
28
-
-
3042524186
-
Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: A phase II study
-
DOI 10.1002/cncr.20349
-
Chang TC, Law KS, Hong JH, Lai CH, Ng KK, Hsueh S, et al. Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study. Cancer 2004; 101: 164-71. (Pubitemid 38812436)
-
(2004)
Cancer
, vol.101
, Issue.1
, pp. 164-171
-
-
Chang, T.-C.1
Law, K.-S.2
Hong, J.-H.3
Lai, C.-H.4
Ng, K.-K.5
Hsueh, S.6
See, L.-C.7
Chang, Y.-C.8
Tsai, C.-S.9
Chou, H.-H.10
Huang, K.-G.11
Liou, J.-D.12
Lin, C.-T.13
Chao, A.14
Chen, M.-Y.15
Wu, T.-I.16
Ma, S.-Y.17
Yen, T.-C.18
-
29
-
-
0035174608
-
Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer
-
Sun SS, Chen TC, Yen RF, Shen YY, Changlai SP, Kao A. Value of whole body 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent cervical cancer. Anticancer Res 2001; 21: 2957-61. (Pubitemid 33051158)
-
(2001)
Anticancer Research
, vol.21
, Issue.4 B
, pp. 2957-2961
-
-
Su, S.-S.1
Che, T.-C.2
Ye, R.-F.3
She, Y.-Y.4
Changla, S.-P.5
Kao, A.6
-
30
-
-
16544387519
-
Defining the priority of using 18F-FDG PET for recurrent cervical cancer
-
18F-FDG PET for recurrent cervical cancer. J Nucl Med 2004; 45: 1632-9. (Pubitemid 47618468)
-
(2004)
Journal of Nuclear Medicine
, vol.45
, Issue.10
, pp. 1632-1639
-
-
Yen, T.-C.1
See, L.-C.2
Chang, T.-C.3
Huang, K.-G.4
Ng, K.-K.5
Tang, S.G.6
Chang, Y.-C.7
Hsueh, S.8
Tsai, C.-S.9
Hong, J.-H.10
Lin, C.-T.11
Chao, A.12
Shih-Ya, M.13
Lin, W.-J.14
Fu, Y.-K.15
Fan, C.-C.16
Lai, C.-H.17
-
31
-
-
33845373398
-
Comparative benefits and limitations of 18F-FDG-PET and CT-MRI in documented or suspected recurrent cervical cancer
-
Yen TC, Lai CH, Ma SY, Huang KG, Huang HJ, Hong JH, et al. Comparative benefits and limitations of 18F-FDG-PET and CT-MRI in documented or suspected recurrent cervical cancer. Eur J Nucl Med Mol Imaging 2006; 33: 1399-407.
-
(2006)
Eur J Nucl Med Mol Imaging
, vol.33
, pp. 1399-1407
-
-
Yen, T.C.1
Lai, C.H.2
Ma, S.Y.3
Huang, K.G.4
Huang, H.J.5
Hong, J.H.6
-
32
-
-
9144272244
-
Restaging recurrent cervical carcinoma with dual-phase [18F]-Fluoro-2-deoxy-D-glucose positron emission tomography
-
Lai CH, Huang KG, See LC, Yen TZ, Tsai CS, Chang TC, et al. Restaging recurrent cervical carcinoma with dual-phase [18F]-Fluoro-2-deoxy-D-glucose positron emission tomography. Cancer 2004; 100: 544-52.
-
(2004)
Cancer
, vol.100
, pp. 544-552
-
-
Lai, C.H.1
Huang, K.G.2
See, L.C.3
Yen, T.Z.4
Tsai, C.S.5
Chang, T.C.6
-
33
-
-
33845514126
-
Role of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in re-recurrent cervical cancer
-
Lin CT, Yen TC, Chang TC, Ng KK, Tsai CS, Ho KC, Lai CH. Role of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in re-recurrent cervical cancer. Int J Gynecol Cancer 2006; 16: 1994-2003.
-
(2006)
Int J Gynecol Cancer
, vol.16
, pp. 1994-2003
-
-
Lin, C.T.1
Yen, T.C.2
Chang, T.C.3
Ng, K.K.4
Tsai, C.S.5
Ho, K.C.6
Lai, C.H.7
-
34
-
-
34250191463
-
18FDG PET) in identifying sites of metastasis prior to pelvic exenteration
-
DOI 10.1016/j.ygyno.2007.03.018, PII S0090825807002168
-
Husain A, Akhurst T, Larson S, Alektiar K, Barakat RR, Chi DS. A prospective study of the accuracy of 18-F-fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration. Gynecol Oncol 2007; 106: 177-80. (Pubitemid 46898590)
-
(2007)
Gynecologic Oncology
, vol.106
, Issue.1
, pp. 177-180
-
-
Husain, A.1
Akhurst, T.2
Larson, S.3
Alektiar, K.4
Barakat, R.R.5
Chi, D.S.6
-
35
-
-
0033838518
-
Posttherapy surveillance of women with cervical cancer: An outcomes analysis
-
DOI 10.1006/gyno.2000.5860
-
Bodurka-Bavers D, Morris M, Eifel PJ, Levenback C, Bevers MW, Lucas KR, Wharton JT. Post-therapy surveillance of women with cervical cancer: an outcome analysis. Gynecol Oncol 2000; 78: 187-93. (Pubitemid 30650352)
-
(2000)
Gynecologic Oncology
, vol.78
, Issue.2
, pp. 187-193
-
-
Bodurka-Bevers, D.1
Morris, M.2
Eifel, P.J.3
Levenback, C.4
Bevers, M.W.5
Lucas, K.R.6
Wharton, J.T.7
-
36
-
-
34848836658
-
Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis?. An Italian multicenter retrospective analysis
-
DOI 10.1016/j.ygyno.2007.07.028, PII S0090825807004994
-
Zola P, Fuso L, Mazzola S, Piovano E, Perotto S, Gadducci A, et al. Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? An Italian multicenter retrospective analysis. Gynecol Oncol 2007; 107(Suppl.): S150-S154. (Pubitemid 47496063)
-
(2007)
Gynecologic Oncology
, vol.107
, Issue.1 SUPPL.
-
-
Zola, P.1
Fuso, L.2
Mazzola, S.3
Piovano, E.4
Perotto, S.5
Gadducci, A.6
Galletto, L.7
Landoni, F.8
Maggino, T.9
Raspagliesi, F.10
Sartori, E.11
Scambia, G.12
-
37
-
-
0025289207
-
A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent cervical carcinoma after radical hysterectomy
-
Soisson AP, Geszler G, Soper JT, Berchuk A, Clarke-Pearson DL. A comparison of symptomatology, physical examination, and vaginal cytology in the detection of recurrent carcinoma after hysterectomy. Obstet Gynecol 1990; 76: 106-9. (Pubitemid 20205229)
-
(1990)
Obstetrics and Gynecology
, vol.76
, Issue.1
, pp. 106-109
-
-
Soisson, A.P.1
Geszler, G.2
Soper, J.T.3
Berchuck, A.4
Clarke-Pearson, D.L.5
-
38
-
-
57649108540
-
Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer
-
Brooks RA, Rader JS, Dehdashti F, Mutch DG, Powell MA, Thaker PH, et al. Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer. Gynecol Oncol 2009; 112: 104-9.
-
(2009)
Gynecol Oncol
, vol.112
, pp. 104-109
-
-
Brooks, R.A.1
Rader, J.S.2
Dehdashti, F.3
Mutch, D.G.4
Powell, M.A.5
Thaker, P.H.6
-
39
-
-
2942642492
-
18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: Response and outcome
-
DOI 10.1200/JCO.2004.09.035
-
Grigsby PW, Siegel BA, Dehdashti F, Rader J, Zoberi I. Posttherapy [18F] flourodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome. J Clin Oncol 2004; 22: 2167-71. (Pubitemid 41095151)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.11
, pp. 2167-2171
-
-
Grigsby, P.W.1
Siegel, B.A.2
Dehdashti, F.3
Rader, J.4
Zoberi, I.5
|